Consequently, safe and effective modalities to improve systemic insulin sensitivity are direly needed not only for counteracting obesity-related type 2 diabetes but may also pave the way for novel therapeutic approaches in wasting diseases. The gene discussed is INS; the disease is type 2 diabetes mellitus.